GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mycotopia Therapies Inc (OTCPK:TPIA) » Definitions » 3-Year EPS without NRI Growth Rate

Mycotopia Therapies (Mycotopia Therapies) 3-Year EPS without NRI Growth Rate : -330.90% (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mycotopia Therapies 3-Year EPS without NRI Growth Rate?

Mycotopia Therapies's EPS without NRI for the three months ended in Mar. 2024 was $-0.03.

During the past 3 years, the average EPS without NRI Growth Rate was -330.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -95.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 6 years, the highest 3-Year average EPS without NRI Growth Rate of Mycotopia Therapies was -119.60% per year. The lowest was -330.90% per year. And the median was -236.20% per year.


Competitive Comparison of Mycotopia Therapies's 3-Year EPS without NRI Growth Rate

For the Medical Care Facilities subindustry, Mycotopia Therapies's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mycotopia Therapies's 3-Year EPS without NRI Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mycotopia Therapies's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Mycotopia Therapies's 3-Year EPS without NRI Growth Rate falls into.



Mycotopia Therapies 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Mycotopia Therapies  (OTCPK:TPIA) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Mycotopia Therapies 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Mycotopia Therapies's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Mycotopia Therapies (Mycotopia Therapies) Business Description

Traded in Other Exchanges
N/A
Address
18851 NE 29th Avenue, Suite 700, Aventura, FL, USA, 33180
Mycotopia Therapies Inc provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions.
Executives
Mark D. Williams director, 10 percent owner, officer: President, CEO & CFO 480 22ND STREET, BOX 2, HEYBURN ID 83336
Gibson Colin director, 10 percent owner, officer: Vice President 480 22ND STREET, BOX 2, HEYBURN ID 83336

Mycotopia Therapies (Mycotopia Therapies) Headlines

From GuruFocus

Four Top Psychedelic Stock Picks for 2021

By Marketwired Marketwired 01-04-2021

Ehave Issues Shareholder Letter and Provides Corporate Update

By GuruFocusNews GuruFocusNews 01-31-2022